Neurosense Therapeutics Ltd (NRSN) is up Tuesday morning, with the stock adding 5.76% in pre-market trading to 1.47. NRSN's short-term technical score of 45 indicates that the stock has traded less bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 96 out of 146 industries, the stock ranks higher than 60% of stocks. Neurosense Therapeutics Ltd has risen 36.27% over the past month, closing at $1.08 on January 30. During this period of time, the stock fell as low as $1.08 and as high as $1.40. NRSN has an average analyst recommendation of Strong Buy. The company has an average price target of $5.25.
NRSN has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on NRSN!